Jens Benn Sørensen

Jens Benn Sørensen

Clinical Associate Professor

Member of:

  • Clinical Oncology


Publication year:
All
11 - 20 out of 106Page size: 10
  1. 2021
  2. Published

    Intracranial effect of osimertinib in relapsed EGFR-mutated T790M-positive and -negative non-small cell lung cancer patients: results from a phase II study

    Eide, I. J. Z., Grut, H., Helland, Å., Ekman, S., Sørensen, Jens Benn, Hansen, K. H., Grønberg, B. H., Cicenas, S., Koivunen, J. P., Mellemgaard, A. & Brustugun, O. T., 2021, In: Acta Oncologica. 60, 12, p. 1565-1571 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Nationwide survival benefit after implementation of first-line immunotherapy for patients with advanced nsclc—real world efficacy

    Mouritzen, M. T., Carus, A., Ladekarl, M., Meldgaard, P., Nielsen, A. W. M., Livbjerg, A., Larsen, J. W., Skuladottir, H., Kristiansen, C., Wedervang, K., Schytte, T., Hansen, K. H., Østby, A. C., Frank, M. S., Lauritsen, J., Sørensen, J. B., Langer, S. W., Persson, G. F., Andersen, J. L., Frary, J. M. C. & 5 others, Drivsholm, L. B., Vesteghem, C., Christensen, H. S., Bjørnhart, B. & Pøhl, M., 2021, In: Cancers. 13, 19, 4846.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. 2020
  5. Published

    Treatment Algorithm for Advanced ALK-Rearranged NSCLC

    Urbanska, E. M., Sørensen, Jens Benn & Santoni Rugiu, Eric, Sep 2020, In: Journal of Thoracic Oncology. 15, 9, p. e156-e157

    Research output: Contribution to journal › Comment/debate › Research › peer-review

  6. Published

    Changing ALK-TKI-Resistance Mechanisms in Rebiopsies of ALK-Rearranged NSCLC: ALK- and BRAF-Mutations Followed by Epithelial-Mesenchymal Transition

    Urbanska, E. M., Sørensen, Jens Benn, Melchior, L. C., Costa, J. C. & Santoni Rugiu, Eric, 2020, In: International Journal of Molecular Sciences (Online). 21, 8, 12 p., 2847.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. 2019
  8. Published

    Intrinsic resistance to EGFR-Tyrosine Kinase Inhibitors in EGFR-Mutant Non-Small Cell Lung Cancer: Differences and Similarities with Acquired Resistance.

    Santoni Rugiu, Eric, Melchior, L. C., Urbanska, E. M., Jakobsen, J. N., Stricker, K. D., Grauslund, M. & Sørensen, Jens Benn, 1 Jul 2019, In: Cancers. 11, 7, 923.

    Research output: Contribution to journal › Review › Research › peer-review

  9. Published

    18F-FDG PET/CT Findings in Disseminated Genital Herpes in an Immunocompetent Patient With Anaplastic Lymphoma Kinase Rearranged Advanced Nonsmall Cell Lung Cancer

    Dejanovic, D., Amtoft, A. G., Sørensen, Jens Benn & Pøhl, M., 2019, In: Clinical Nuclear Medicine. 44, 5, p. e351-e352

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Nintedanib in combination with pemetrexed and cisplatin for chemotherapy-naive patients with advanced malignant pleural mesothelioma (LUME-Meso): a double-blind, randomised, placebo-controlled phase 3 trial

    Scagliotti, G. V., Gaafar, R., Nowak, A. K., Nakano, T., van Meerbeeck, J., Popat, S., Vogelzang, N. J., Grosso, F., Aboelhassan, R., Jakopovic, M., Ceresoli, G. L., Taylor, P., Orlandi, F., Fennell, D. A., Novello, S., Scherpereel, A., Kuribayashi, K., Cedres, S., Sørensen, J. B., Pavlakis, N. & 6 others, Reck, M., Velema, D., von Wangenheim, U., Kim, M., Barrueco, J. & Tsao, A. S., 2019, In: The Lancet Respiratory Medicine. 7, 7, p. 569-580 12 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    Very Early Response Evaluation by PET/MR in Patients with Lung Cancer: Timing and Feasibility

    Langer, N. H., Langer, Seppo W., Johannesen, H. H., Hansen, A. E., Costa, J., Klausen, T. L., Forman, Julie Lyng, Olin, A., Rasmussen, S. H., Sørensen, Jens Benn, Löfgren, J., Kjær, A. & Fischer, B. M., 2019, In: Diagnostics. 9, 1, 13 p., 35.

    Research output: Contribution to journal › Journal article › Research › peer-review

  12. 2018
  13. Published

    Molecular prediction of adjuvant cisplatin efficacy in Non-Small Cell Lung Cancer (NSCLC)—validation in two independent cohorts

    Buhl, I. K., Santoni Rugiu, Eric, Ravn, J., Hansen, A., Christensen, I. J., Jensen, T., Pratt, B., Askaa, J., Jensen, P. B., Knudsen, S. & Sørensen, Jens Benn, 22 Mar 2018, In: PLOS ONE. 13, 3, 18 p., e0194609.

    Research output: Contribution to journal › Journal article › Research › peer-review

  14. Published

    Changing Resistance Mechanisms in Rebiopsies of ALK-Positive NSCLC During Multiple Lines of Therapy: ALK/BRAF-Mutations Followed By EMT

    Urbanska, E., Melchior, L., De Stricker, K., Sørensen, Jens Benn & Rugiu, E. S., 2018, In: Journal of Thoracic Oncology. 13, 10, p. S946 1 p.

    Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Previous 1 2 3 4 5 6 7 8 ...11 Next

ID: 34406177